ObjectivesTo assess deviations in longitudinally measured cytokines with preterm birth (PTB).MethodsProspective longitudinal study targeting 80 subjects. Phlebotomy specimens for broad panel of cytokine analysis were obtained at three time (T) intervals: first trimester (T1: 8-14 weeks' gestation), second trimester (T2: 18-22 weeks' gestation), and third trimester (T3: 28-32 weeks' gestation). Important demographics and outcomes were tracked. Data were stratified and the target groups were analyzed as follows: "Uncomplicated" (delivered ≥37 weeks) or "Preterm Birth" (<37 weeks). Generalized Linear Modeling determined rate of change T1-T3 by outcome.ResultsComplete data replete with phlebotomy at all thr...
Currently known risk factors explain only a small fraction of preterm birth (PTB). Previous PTB is o...
Background: Preterm birth (PTB), defined as birth before 37 weeks of gestation, accounts for most ne...
Birth by cesarean section is associated with increased risks of immune disorders. We tested whether ...
ObjectivesTo assess deviations in longitudinally measured cytokines with preterm birth (PTB).Methods...
BACKGROUND: Preterm birth (PTB) is hypothesized to be an inflammatory response disease. However, no ...
Complete cytokine profile from at 35 to 36 weeks (visit 3). Data presented as density percentage wit...
Complete cytokine profile from at 26 to 28 weeks (visit 2). Data presented as density percentage wit...
Objective: To assess differences in cytokine levels in cervicovaginal fluid (CVF) and serum across t...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/108274/1/aji12265.pd
The immune system represents a leading pathway of interest in the pathophysiology of preterm birth. ...
Pregnancy implies delicate immunological balance between two individuals, with constant changes and ...
Multi-marker tests hold promise for identifying symptomatic women at risk of imminent preterm delive...
Introduction Human pregnancy is a state of elevated maternal systemic inflammation, and pregnancy co...
Preterm birth occurs in 11% of live births globally and accounts for 35% of all newborn deaths. Pret...
Complete cytokine profile from initial evaluation at 11 to 16 weeks (visit 1). Data presented as pix...
Currently known risk factors explain only a small fraction of preterm birth (PTB). Previous PTB is o...
Background: Preterm birth (PTB), defined as birth before 37 weeks of gestation, accounts for most ne...
Birth by cesarean section is associated with increased risks of immune disorders. We tested whether ...
ObjectivesTo assess deviations in longitudinally measured cytokines with preterm birth (PTB).Methods...
BACKGROUND: Preterm birth (PTB) is hypothesized to be an inflammatory response disease. However, no ...
Complete cytokine profile from at 35 to 36 weeks (visit 3). Data presented as density percentage wit...
Complete cytokine profile from at 26 to 28 weeks (visit 2). Data presented as density percentage wit...
Objective: To assess differences in cytokine levels in cervicovaginal fluid (CVF) and serum across t...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/108274/1/aji12265.pd
The immune system represents a leading pathway of interest in the pathophysiology of preterm birth. ...
Pregnancy implies delicate immunological balance between two individuals, with constant changes and ...
Multi-marker tests hold promise for identifying symptomatic women at risk of imminent preterm delive...
Introduction Human pregnancy is a state of elevated maternal systemic inflammation, and pregnancy co...
Preterm birth occurs in 11% of live births globally and accounts for 35% of all newborn deaths. Pret...
Complete cytokine profile from initial evaluation at 11 to 16 weeks (visit 1). Data presented as pix...
Currently known risk factors explain only a small fraction of preterm birth (PTB). Previous PTB is o...
Background: Preterm birth (PTB), defined as birth before 37 weeks of gestation, accounts for most ne...
Birth by cesarean section is associated with increased risks of immune disorders. We tested whether ...